The government approved Takeda’s human protein C to treat severe congenital protein C deficiency, an extremely rare disease with only 13 Korean cases reported so far.On Tuesday, the Ministry of Food and Drug Safety authorized the use of Ceprotin (ingredient: human protein C) to prevent and treat ven
Vuno said it has obtained the Ministry of Food and Drug Safety (MFDS) certification for Hativ Pro, a personal electrocardiogram (ECG) device.The device is the first hardware medical device rolled out by VUNO that measures the ECG and records, stores, and transmits data.The company said the small and
The recent death of a nurse at Asan Medical Center (AMC) who suffered a cerebral hemorrhage while on duty is rocking the medical community to the core. AMC is regarded as one of the best among Korea’s five largest hospitals.Health industry officials are wondering why AMC with top medical facilities
The accumulated Covid-19 caseload in Korea neared 20 million on Tuesday, meaning that almost two of five Koreans have tested positive for the virus.The country reported 111,789 more new virus cases on Tuesday, raising the total caseload to 19,932,439, according to the Korea Disease Control and Preve
GC Biopharma announced on Monday that operating profit for the second quarter of 2022 jumped by 18 percent on year recording 13.1 billion won ($10 million).Sales stood at 423.2 billion won in the second quarter, up 9.2 percent year-on-year. Net profit jumped 45.3 percent to 10.9 billion won in the s
Genencell said Tuesday it obtained approval from Drugs Controller General of India (DCGI) to conduct phase 2/3 trial of ES16001 (pipeline name: GNC102), an oral Covid-19 treatment candidate.The biotech firm is conducting Covid-19 drug trials in multiple countries.In October, it received the nod to c
A team of researchers at Asan Medical Centre (AMC) developed a lymphatic channel sheet (LCS) to restore the flow of damaged lymph nodes to prevent lymphedema after cancer treatment.Radiation therapy is often performed to resect the metastasized lymph node and reduce cancer recurrence. At this time,
Samjin Pharmaceutical signed an agreement with Cyclica, a Canadian AI-based novel drug development platform company, for a joint research on AI novel drug development.Under the agreement, Samjin Pharmaceutical will propose several potential drug candidates to Cyclica, and Cyclica will apply its AI-b
Helixmith is facing additional delays in receiving a recommendation from the Independent Data Monitoring Committee (IDMC) for its U.S. phase 3 clinical trial of Engensis (VM202), its diabetic peripheral neuropathy (DPN) treatment.Industry sources said the IDMC interim results could predict whether t
Samsung Biologics said on Tuesday it completed the first engineering run of its one-stop production system for large-scale commercial production of mRNA Covid-19 vaccine raw materials, following the contract manufacturing organization (CMO) for Moderna's mRNA vaccine.Greenlight Bioscience and Samsun
The government has been dragging its feet to review insurance benefits for Roche’s new spinal muscular atrophy (SMA) oral drug Evrysdi (ingredient: risdiplam) for over a year because it wants to review it together with expanded insurance coverage for the existing SMA drug Spinraza (nusinersen), sour
ST Pharm announced on Monday it won the U.S. FDA’s current Good Manufacturing Practice (cGMP) certification for its oligonucleotide (oligo) plant in Korea, for the first time in Asia.An FDA inspection team visited ST Pharm’s oligo factory in Banwol in Ansan in May and conducted a pre-approval inspec
Starting Monday, the government stopped conducting daily health monitoring phone calls to high-risk Covid-19 patient groups, including those over 60 or immunocompromised people undergoing at-home treatment.The government had classified those over 60 and immunocompromised people as the intensive at-h
A research team at St. Mary's Hospital has discovered that T cell, which causes autoimmune liver disease, appears after a liver biopsy on patients who received the Covid-19 vaccine.The research, conducted by Professors Sung Pil-soo at Seoul St. Mary's Hospital and Lee Sun-kyu at Incheon St. Mary's H
The Korea Atomic Energy Research Institute (KAERI) said Monday that its Advanced Radiation Technology Institute has developed a precision prediction model for radiation’s damage to DNA for the first time.By precisely predicting the level of radiation’s damage on DNA, medical professionals can evalua
Novartis Korea said Monday that it released Zolgensma, the nation's first gene replacement treatment for spinal muscular atrophy (SMA), on Monday with the registration of health insurance benefits.SMA is a fatal rare genetic disease and one of the main causes of infant death, in which muscles gradua
Almost half of 125 Korean clinics and hospitals have expanded their operations in China so far, and more than a third of them were in the dermatology and plastic surgery fields, a report showed.The Korea Health Industry Development Institute (KHIDI) released a report on Korean medical institutions’
Celltrion began the domestic sale of its Alzheimer's dementia treatment, Donerion Patch (ingredient name: donepezil), on Monday.Donerion, the first patch-type donepezil-based dementia treatment worldwide, received approval from the Ministry of Food and Drug Safety (MFDS) in November and began to get
Becton Dickinson (BD) Korea said it has completed Bard Korea's acquisition and integrated its Korean legal entity into BD Korea from Monday.BD, a global medical technology company, acquired Bard for $24 billion in 2017. However, the two companies have been operating as independent corporations in Ko
Patients with nervous system disorders such as stroke and cerebral hemorrhage need intensive treatment in the “golden hour.” To do so, hospitals need to increase the number of neurointensivists within the intensive care units (ICUs), an expert said.More than half of the patients in ICUs at tertiary